Around the Net
Pfizer Takes Kidney Cancer Drug Overseas
- Fox Business , Wednesday, September 5, 2012 10:45 AM
Pfizer Inc. has received marketing authorization from the European Commission for its kidney cancer drug, Inlyta, meant to treat adults with an advanced type of kidney cancer.
